The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (3.571%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 28.50
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes

28 Oct 2014 07:00

RNS Number : 4197V
Ilika plc
28 October 2014
 



Ilika plc

("Ilika" or the "Company")

 

Directorate Changes

 

Ilika (AIM: IKA), the accelerated materials innovation company, announces the appointment of Keith Jackson as Non-Executive Director effective January 2015, and the beginning of succession planning for the role of non-Executive Chairman. Current Non-Executive Chairman Jack Boyer, has indicated to the Board that after 10 years in the position, he intends to stand down from his role.

 

Jack Boyer - Non-Executive Chairman

 

Jack Boyer, having recently celebrated a decade of successful leadership as Non-Executive Chairman of Ilika, will be stepping down from the board. Jack announced his intention to stand down at a time when the share price has reached historic highs following the achievement of a series of significant milestones in the Company's development. Ilika's Senior Independent Director, Professor Sir William Wakeham, has been appointed to lead the succession process.

 

Jack Boyer commented: "I have greatly enjoyed my tenure at Ilika but it is good governance practice to rotate board appointments and this is a timely opportunity to conduct a thorough search process and effect an orderly handover to support the future development of the Company."

 

Commenting on this announcement, Graeme Purdy, CEO added: "Jack's contribution to the team over the past ten years has been first class. He has helped to steer the Company through three rounds of venture finance, its IPO in 2010 and contributed to the progress that has resulted in substantial share price growth since flotation. We respect his decision to move on to other challenges having contributed extensively to the development of Ilika from University spin-out to a globally-respected commercial organisation."

 

Keith Jackson - appointment as Non-Executive

 

In a further move to strengthen the Board, Keith Jackson will be appointed as an additional Non-Executive Director to Ilika's board effective January 2015. Keith is currently the Chief Technology Officer at Meggitt plc, the FTSE 100 engineering group, where he is responsible for technology direction and strategy. Keith was previously Chief Technology Officer of Electrical power and control systems at Rolls Royce, having been owner and Managing Director of Pi Technology, which was acquired by Ford.

 

Keith brings considerable expertise in the industrial commercialisation of control systems to Ilika at a time when the Company is preparing for the roll out of its solid state battery technology for wireless sensor networks. He offers a combination of valuable experience in growing entrepreneurial ventures (Pi Technology) and developing complex systems for industrial deployment (Meggitt and Rolls Royce).

 

On Keith's appointment, Graeme Purdy, Ilika's CEO, commented: "This is a very exciting period for Ilika as a number of the materials we have been developing become commercially mature. Ilika's board has always played an important role in setting strategic direction and we have appointed Keith to strengthen our technology commercialisation experience."

 

 

For more information contact:

 

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Numis Securities Limited

Tel: 020 7260 1000

Oliver Cardigan, Nominated Adviser

 

James Black, Corporate Broking

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 / ilika@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Paul Cornelius

Mob: 07827 879 460

 

Regulatory disclosures

 

Keith Jackson, (age 54) has not been a director or partner of a company or partnership during the previous five years.

 

Keith Jackson, holds no shares in the Company and there is no further information to be disclosed under Schedule Two, paragraph (g) and Rule 17 of the AIM Rules Companies.

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGGRAUUPCPGM
Date   Source Headline
13th May 202410:16 amRNSPosting of Circular & Notice of General Meeting
10th May 20243:02 pmRNSResult of Placing
10th May 20247:00 amRNSProposed Placing and Open Offer & Notice of GM
26th Apr 20247:00 amRNSAgratas joins Goliath industrialisation programme
23rd Apr 20247:00 amRNSCapital Markets Day and Trading Update
27th Mar 20247:00 amRNSNotice of Capital Markets Day and Investor Q&A
23rd Jan 20247:00 amRNSHalf-year Report
15th Jan 20247:00 amRNS2024 Conference Schedule
14th Dec 20231:46 pmRNSAward of Share Options, Exercise of Options & TVR
13th Dec 20231:43 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSLithium-ion parity development milestone
24th Nov 20237:00 amRNSTrading Update, Notice of Results & Presentations
20th Nov 20237:00 amRNSKey Technology Development Milestone
9th Oct 20237:00 amRNSAward of Scale-up Grant Funding for Goliath
20th Sep 20233:20 pmRNSResult of AGM & Award of Executive Share Options
18th Aug 20237:00 amRNSPosting of Annual Report and Notice of AGM
4th Aug 20237:00 amRNSSigned agreement with Cirtec Medical
13th Jul 20237:00 amRNSFinal Results
16th Jun 20237:00 amRNSSenior appointment&conversion of preference shares
22nd May 20237:00 amRNSTrading Update & Notice of Results
11th May 20237:00 amRNSFirst Customer Shipments of Stereax M300 Batteries
26th Apr 20237:00 amRNSExercise of Options and Total Voting Rights
11th Apr 20237:00 amRNSFirst Customer Shipment of Stereax® Batteries
8th Mar 20234:35 pmRNSPrice Monitoring Extension
1st Mar 20237:00 amRNSAward of Share Options
31st Jan 202310:30 amRNSDirector/PDMR Shareholding
30th Jan 20232:05 pmRNSSecond Price Monitoring Extn
30th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Jan 202311:05 amRNSSecond Price Monitoring Extn
30th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20232:05 pmRNSSecond Price Monitoring Extn
26th Jan 20232:00 pmRNSPrice Monitoring Extension
26th Jan 202311:05 amRNSSecond Price Monitoring Extn
26th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20239:05 amRNSSecond Price Monitoring Extn
26th Jan 20239:00 amRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSAward of Grant Funding for Goliath
19th Jan 20237:00 amRNSHalf-year Report
16th Jan 20237:00 amRNSMOU signed with Cirtec Medical
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
28th Dec 20224:40 pmRNSSecond Price Monitoring Extn
28th Dec 20224:35 pmRNSPrice Monitoring Extension
28th Dec 20222:05 pmRNSSecond Price Monitoring Extn
28th Dec 20222:00 pmRNSPrice Monitoring Extension
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
21st Nov 20221:29 pmEQSIlika 'well positioned' to deliver battery product combination

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.